The experimental product isolates and purifies factors released by lab-grown iPS-derived cells, with foundational studies examining age-related changes in tissues including skin and hair.
Longeveron received a $1 million milestone award to test laromestrocel’s potential to reduce aging frailty and improve muscle, cognitive and immune function in older adults.
PLA General Hospital has begun recruiting 2,000 adults aged 50 and older for a multicenter randomized trial to assess whether an approved umbilical cord mesenchymal stem cell therapy can safely improve aging-related...
The company is working on iPSC-derived, AAV, and small molecule therapies for neurodegenerative, orthopedic, and blood-based disorders, with the help of OpenAI's models which seem to be accelerating life science research.
Dr. Joshua Hare's Longeveron is working on MSC therapy for seniors with "inflammaging", securing a new method-of-use patent with the USPTO.